Arthur LM - Search Results

1

Changes in PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer.

Arthur LM, Turnbull AK, Renshaw L, Keys J, Thomas JS, Wilson TR, Lackner MR, Sims AH, Dixon JM. Arthur LM, et al. Breast Cancer Res Treat. 2014 Aug;147(1):211-9. doi: 10.1007/s10549-014-3080-x. Epub 2014 Aug 9. Breast Cancer Res Treat. 2014. PMID: 25104442

2

Molecular changes in lobular breast cancers in response to endocrine therapy.

Arthur LM, Turnbull AK, Webber VL, Larionov AA, Renshaw L, Kay C, Thomas JS, Dixon JM, Sims AH. Arthur LM, et al. Cancer Res. 2014 Oct 1;74(19):5371-6. doi: 10.1158/0008-5472.CAN-14-0620. Epub 2014 Aug 6. Cancer Res. 2014. PMID: 25100562

3

Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer.

Turnbull AK, Arthur LM, Renshaw L, Larionov AA, Kay C, Dunbier AK, Thomas JS, Dowsett M, Sims AH, Dixon JM. Turnbull AK, et al. Among authors: arthur lm. J Clin Oncol. 2015 Jul 10;33(20):2270-8. doi: 10.1200/JCO.2014.57.8963. Epub 2015 Jun 1. J Clin Oncol. 2015. PMID: 26033813 Free article.

4

Tumour sampling method can significantly influence gene expression profiles derived from neoadjuvant window studies.

Pearce DA, Arthur LM, Turnbull AK, Renshaw L, Sabine VS, Thomas JS, Bartlett JM, Dixon JM, Sims AH. Pearce DA, et al. Among authors: arthur lm. Sci Rep. 2016 Jul 7;6:29434. doi: 10.1038/srep29434. Sci Rep. 2016. PMID: 27384960 Free PMC article.

5

Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.

Martínez-Pérez C, Turnbull AK, Ekatah GE, Arthur LM, Sims AH, Thomas JS, Dixon JM. Martínez-Pérez C, et al. Among authors: arthur lm. Cancer Treat Rev. 2017 Apr;55:163-172. doi: 10.1016/j.ctrv.2017.03.009. Epub 2017 Mar 31. Cancer Treat Rev. 2017. PMID: 28402908 Free article. Review.

6

Margin width and local recurrence after breast conserving surgery for ductal carcinoma in situ.

Ekatah GE, Turnbull AK, Arthur LM, Thomas J, Dodds C, Dixon JM. Ekatah GE, et al. Among authors: arthur lm. Eur J Surg Oncol. 2017 Nov;43(11):2029-2035. doi: 10.1016/j.ejso.2017.08.003. Epub 2017 Sep 4. Eur J Surg Oncol. 2017. PMID: 28917445 Free article.

7

Pre-operative Endocrine Therapy.

Arthur LM, Turnbull AK, Khan LR, Dixon JM. Arthur LM, et al. Curr Breast Cancer Rep. 2017;9(4):202-209. doi: 10.1007/s12609-017-0255-6. Epub 2017 Oct 27. Curr Breast Cancer Rep. 2017. PMID: 29201277 Free PMC article. Review.

8

Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies.

Dixon JM, Cameron DA, Arthur LM, Axelrod DM, Renshaw L, Thomas JS, Turnbull A, Young O, Loman CA, Jakubowski D, Baehner FL, Singh B. Dixon JM, et al. Among authors: arthur lm. Adv Ther. 2019 Apr;36(4):828-841. doi: 10.1007/s12325-019-0896-0. Epub 2019 Mar 11. Adv Ther. 2019. PMID: 30859501

9

Current use of drains and management of seroma following mastectomy and axillary surgery: results of a United Kingdom national practice survey.

Fairhurst K, Roberts K, Fairbrother P, Potter S; Diamond Study Collaborative. Fairhurst K, et al. Breast Cancer Res Treat. 2024 Jan;203(2):187-196. doi: 10.1007/s10549-023-07042-7. Epub 2023 Oct 25. Breast Cancer Res Treat. 2024. PMID: 37878150 Free PMC article.

10

A phase II trial of mitomycin, ifosfamide and cisplatin in recurrent carcinoma of the cervix.

Trudeau M, Seymour R, Stanimir G, Souhami L, Arthur L, Dulude H, Gallant G, Leyland-Jones B. Trudeau M, et al. Int J Gynecol Cancer. 2000 May;10(3):207-211. doi: 10.1046/j.1525-1438.2000.010003207.x. Int J Gynecol Cancer. 2000. PMID: 11240676

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page